MedTrace Logo

Bupivacaine Effectivity and Efficiency for Regional Spinal Anesthesia in Non-ERACS and ERACS Caesarean Section

NCT06640816 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-10-15

No results posted yet for this study

Summary

The most widely used regional anesthesia technique in Indonesia today is regional anesthesia with the subarachnoid (spinal) blockade method. In its development, this technique is not only used for surgery in the lower abdomen area, but also used as a management of acute pain. Especially for cases of pregnant patients undergoing cesarean section, in its development a method known as enhanced regional anesthesia for c-section (ERACS) emerged.

This technique is widely preferred by most patients. ERACS is considered very beneficial for patients, because this technique promises faster mobility after surgery with a longer duration of pain compared to conventional spinal regional anesthesia techniques.

The data collected from this study is secondary data derived from the medical records of patients in 2 private hospitals in Purbalingga Regency, which are taken and sorted systematically according to needs.

This study was conducted based on the situation and condition of health services in Indonesia which are highly dependent on state funding through the national health insurance system. The state funding emphasizes the effectiveness and efficiency of health services, including surgical and related procedures.

The question of this research :

1. Is Bupivacaine in ERACS patients better than Non-ERACS based on BMI and height?
2. Is Bupivacaine in ERACS patients more effective and efficient than Non-ERACS based on BMI and height?

Conditions

  • Patients with ASA Physical Status 1 - 2 Who Undergo Surgical Delivery (cesarean Section)

Sponsors & Collaborators

  • Universitas Jenderal Soedirman

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2023-12-30
Completion
2023-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06640816 on ClinicalTrials.gov